SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) and Transcriptic Inc. have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research. Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating with rising companies such as Transcriptic to develop novel synthetic biology […]
Washington University School of Medicine first partner to adopt company-centric workflow for immuno-oncology research CARLSBAD, Calif.–Thermo Fisher Scientific today announced its Center of Excellence in Immunotherapy Program designed to build strategic collaborations and accelerate research and clinical trials in immuno-oncology around the globe. The Washington University School of Medicine is the first institution to partner […]
BERGISCH GLADBACH – Miltenyi Biotec has expanded its antibody portfolio and now offers more than 500 new recombinantly engineered antibodies – the REAfinity™ Antibodies optimized for flow cytometry. These antibodies display considerable advantages over conventional monoclonal antibodies and their introduction thereby contributes significantly to the standardization of antibodies in research. Recently, there has been an intense discussion […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Sam A. Samad, Senior Vice President and Chief Financial Officer. He will join the company on January 6th, 2017. Sam will be responsible for the company’s finance, accounting, investor relations, internal audit and treasury functions. He joins Illumina from Cardinal Health where he held several senior leadership positions including most recently […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today it has named Dr. Dan Kephart as its chief science officer — a new position for the company. Kephart will assume his responsibilities at Neogen effective Jan. 1. Kephart has served as research and development director for the agribusiness unit of Thermo Fisher Scientific, as well […]
Kevin Ness brings expertise in commercializing innovative products for the biotechnology industry Boulder CO – Muse bio, a privately-held company leading the development of next-generation genome engineering technologies, today announced that Dr. Kevin Ness has been appointed Chief Executive Officer and member of the Board of Directors. Kevin succeeds Muse bio’s founding CEO Ryan Gill, […]
Desktop Genetics and LGC have been awarded funding from SynbiCITE, the UK’s national center for the commercialization of synthetic biology, to develop screening and validation tools for functional genomics, cell line engineering and synthetic biology. Desktop Genetics and LGC will develop a novel pipeline for rapid assessment of CRISPR-mediated editing efficiencies. They will assess and develop two […]
Product offers smaller sample volumes and four times higher throughput than traditional assays Billerica, Massachusetts — MilliporeSigma today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays. The new panel allows researchers to achieve four times higher throughput than traditional assays while using smaller sample sizes. […]
Bibby Scientific Ltd announced today that it will be taking over the distribution of Argos Technologies products, outside of the USA and Asia Pacific, from December 2016. As Bibby Scientific and Argos Technologies are now both part of the Cole-Parmer group, this gives the company an opportunity to streamline customer experience in the EMEA market. […]
SEATTLE — The Allen Institute for Cell Science has released the Allen Cell Collection: the first publicly available collection of gene edited, fluorescently tagged human induced pluripotent stem cells that target key cellular structures with unprecedented clarity. Distributed through the Coriell Institute for Medical Research, these powerful tools are a crucial first step toward visualizing the dynamic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
